| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/14/2013 | US20130039853 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/14/2013 | CA2851575A1 Methods and compositions for inhibiting delayed graft function |
| 02/14/2013 | CA2844792A1 Use of cardiotrophin-1 for the treatment of kidney diseases |
| 02/14/2013 | CA2844749A1 Novel compositions and uses thereof |
| 02/14/2013 | CA2844668A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 02/14/2013 | CA2844619A1 Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
| 02/14/2013 | CA2844587A1 Oligodendrocyte differentiation |
| 02/14/2013 | CA2844283A1 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/14/2013 | CA2844282A1 Composition for controlled ovarian stimulation |
| 02/14/2013 | CA2843837A1 Methods and compositions for improving sperm functionality |
| 02/14/2013 | CA2843640A1 N-glycosylated insulin analogues |
| 02/14/2013 | CA2843586A1 Injectable solution of at least one type of basal insulin |
| 02/14/2013 | CA2843558A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| 02/14/2013 | CA2843556A1 Method for dissolution testing of solid compositions containing digestive enzymes |
| 02/14/2013 | CA2842492A1 P97 fragments with transfer activity |
| 02/14/2013 | CA2842281A1 Constitutively active upar variants and their use for the generation and isolation of inhibitory antibodies |
| 02/14/2013 | CA2841874A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/13/2013 | EP2557164A1 Induced activation in dendritic cells |
| 02/13/2013 | EP2557155A1 Metal salen complex derivative and process for production thereof |
| 02/13/2013 | EP2557089A2 Compositions and methods for immunomodulation |
| 02/13/2013 | EP2557088A1 Physiologically active peptides |
| 02/13/2013 | EP2556840A2 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene |
| 02/13/2013 | EP2556839A2 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure |
| 02/13/2013 | EP2556838A1 Romidepsin-based treatments for cancer |
| 02/13/2013 | EP2556086A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 02/13/2013 | EP2556043A2 New polyterpene type compounds, compositions containing them and topical uses thereof |
| 02/13/2013 | EP2555820A2 Preservative-free follicle stimulating hormone solution delivery device |
| 02/13/2013 | EP2555802A1 Methods and compositions for enhanced delivery of compounds |
| 02/13/2013 | EP2555793A1 Methods for modeling protein stability |
| 02/13/2013 | EP2555792A2 Proteases for degrading gluten |
| 02/13/2013 | EP2555791A1 Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist |
| 02/13/2013 | EP2555790A1 THERAPEUTIC USE OF THE ß2m PROTEIN |
| 02/13/2013 | EP2555789A1 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof |
| 02/13/2013 | EP2555788A1 Methods and compositions for cardioprotection and cardioregeneration |
| 02/13/2013 | EP2555753A2 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems |
| 02/13/2013 | EP2555618A1 Methods of using diacerein as an adjunctive therapy for diabetes |
| 02/13/2013 | EP2555611A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals |
| 02/13/2013 | CN1953988B Peptides derived from human BPLP protein, polynucleotides coding for the peptides and antibodies directed against the peptides |
| 02/13/2013 | CN1931360B Double timephase neo-insulin zinc injection (30%) and prepn process thereof |
| 02/13/2013 | CN102933598A Novel glucagon analogues |
| 02/13/2013 | CN102933227A Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
| 02/13/2013 | CN102933226A Secondary structure stabilized nmda receptor modulators and uses thereof |
| 02/13/2013 | CN102933225A Surfactant composition |
| 02/13/2013 | CN102933224A Compounds for use in the treatment of diseases based on the expression of toxic transcripts |
| 02/13/2013 | CN102933223A Casein peptide for use in the treatment of uterine infections |
| 02/13/2013 | CN102933200A One-phase gel composition comprising phospholipids |
| 02/13/2013 | CN102925522A Method for preparing pilose antler peptide dry powder by enzymolysis method |
| 02/13/2013 | CN102925472A Recombinant expression of actinoporins proteins |
| 02/13/2013 | CN102925447A peptidoglycan binding protein BjApextrin1 and BjApextrin2, and genes, production method and application thereof |
| 02/13/2013 | CN102925422A Agkistrodon acutus hemocoagulase-B |
| 02/13/2013 | CN102925415A Silkworm recombination baculovirus expressing paraoxonase 1 gene and preparation method and application thereof |
| 02/13/2013 | CN102925403A Recombinant strain capable of expressing fungal immunomodulatory protein from Flammulina velutipes (FIP-fve), construction method, protein expression and purification method, and protein application |
| 02/13/2013 | CN102924606A Antitumor and thrombolytic double-effect chimeric protein of targeting tumor cell, preparation method and application thereof |
| 02/13/2013 | CN102924604A Recombined vessel endothelium growth factor receptor, encoding genes thereof and application |
| 02/13/2013 | CN102924589A Glucagon-like peptide-2 (GLP-2) analog, and preparation method and use thereof |
| 02/13/2013 | CN102924587A Long-acting salmon calcitonin analog, and preparation method and use thereof |
| 02/13/2013 | CN102924585A Neublastin variants |
| 02/13/2013 | CN102924584A Recombinant lubricin molecules and uses thereof |
| 02/13/2013 | CN102924579A Polypeptide with function of increasing activities of human NK (Natural Killer) and NKT (Natural Killer T) cells for killing tumor cells and application of polypeptide |
| 02/13/2013 | CN102924578A Anti-tumor polypeptide, preparation method and anti-tumor applications thereof |
| 02/13/2013 | CN102924574A Antibacterial peptide LZ1 and application of antibacterial peptide in preparation of antibacterial medicament |
| 02/13/2013 | CN102924573A Actin binding peptide and purpose thereof |
| 02/13/2013 | CN102924567A Peptide compound and preparation method and use of peptide compound |
| 02/13/2013 | CN102924562A Dry heat treatment stabilizer for human blood coagulation factor VIII and application thereof |
| 02/13/2013 | CN102921020A Gene drug for combined treatment on tumors, and use thereof |
| 02/13/2013 | CN102921014A Biocompatible nano composite drug carrier with synergistic anti-tumor effect, drug with synergistic anti-tumor effect and preparation methods of biocompatible nano composite drug carrier and drug |
| 02/13/2013 | CN102921007A Method and reagent used for controlling insulin resistance and diabetes mellitus |
| 02/13/2013 | CN102921001A Plant-derived anti-rabies compound spraying agent |
| 02/13/2013 | CN102921000A Application of acetylcholinesterase as nuclease |
| 02/13/2013 | CN102920999A Application of Chinese yarn glycoprotein in preparation of medicament for treating nephritis and renal hypertension |
| 02/13/2013 | CN102920998A Application of Chinese yarn glycoprotein in improvement of activities of oxidative metabolism enzymes of mitochondria of brain cell |
| 02/13/2013 | CN102920997A Compound tinea ointment |
| 02/13/2013 | CN102920996A Impaired wound healing compositions and treatments |
| 02/13/2013 | CN102920995A Drug composition for treating liver injury |
| 02/13/2013 | CN102920994A Pharmaceutical composition containing animal bone polypeptide |
| 02/13/2013 | CN102920993A Medicament for treating oestrus failure and infertility of female livestock |
| 02/13/2013 | CN102920992A Injection recombinant follistatin preparation and preparation method |
| 02/13/2013 | CN102920991A Application of composition of Chinese yarn polysaccharide and Chinese yarn protein |
| 02/13/2013 | CN102920717A Applications of stachyose in hangover alleviating |
| 02/13/2013 | CN102920685A Lysozyme film agent for eyes and preparation method thereof |
| 02/13/2013 | CN102920664A Preparation method of long-term oral insulin sustained-release microspheres |
| 02/13/2013 | CN102920658A Liposome combined with GLP-1 (Glucagon-Like Peptide-1) analogue and polyethylene glycol and preparation method of liposome |
| 02/13/2013 | CN102919850A Composition for nutritional food and drugs |
| 02/13/2013 | CN102526758B Stable aqueous solution of pegylation interferon |
| 02/13/2013 | CN102526757B Stable aqueous solution of pegylation interferon |
| 02/13/2013 | CN102342918B Colon-targeting coating system, colon-targeting oral preparation and preparation method of colon-targeting oral preparation |
| 02/13/2013 | CN102293748B Oral PEGylated insulin pH-sensitive naonparticle and preparation method thereof |
| 02/13/2013 | CN102268068B Substrate metal prolease-9 polypeptide inhibitor 1and application thereof |
| 02/13/2013 | CN102206285B Chimeric peptide based on endomorphins 2 and neuropeptides FF, and synthesis and application thereof |
| 02/13/2013 | CN101851294B Cell-penetrating peptide (Arg) 9 and lidamycin fusion protein (Arg) 9-LDP |
| 02/13/2013 | CN101822823B Fibrinogen-420 and new application of active structure domain thereof |
| 02/13/2013 | CN101810847B Inflammation-inhibiting compounds |
| 02/13/2013 | CN101805784B Single nucleotide polymorphism of human WNK4 genes and application thereof |
| 02/13/2013 | CN101804196B Soybean-based whole protein type enteral nutrition powder and preparation method thereof |
| 02/13/2013 | CN101768580B Novel fibrinolysin and preparation method and use thereof |
| 02/13/2013 | CN101534852B Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 02/13/2013 | CN101528197B Dried reconstituted vesicle formation for pharmaceutical application |
| 02/13/2013 | CN101439015B Pharmaceutical composition with enhanced bioavailability |
| 02/13/2013 | CN101371921B Instant lyophilized fibrinogen and fibrin ferment formulation composition, preparation method and use thereof |
| 02/13/2013 | CN101357223B Preparation method of anti-stress agent for fishing |